122 related articles for article (PubMed ID: 14523629)
1. Specific modulation of sigma binding sites by the anxiolytic drug opipramol.
Holoubek G; Müller WE
J Neural Transm (Vienna); 2003 Oct; 110(10):1169-79. PubMed ID: 14523629
[TBL] [Abstract][Full Text] [Related]
2. Neuropharmacology of the anxiolytic drug opipramol, a sigma site ligand.
Müller WE; Siebert B; Holoubek G; Gentsch C
Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S189-97. PubMed ID: 15547785
[TBL] [Abstract][Full Text] [Related]
3. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
[TBL] [Abstract][Full Text] [Related]
4. [Opipramol in behavioral pharmacologic anxiety and depression models].
Gentsch C
Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S17-20. PubMed ID: 9922922
[No Abstract] [Full Text] [Related]
5. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
Vicente MA; Zangrossi H
Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
[TBL] [Abstract][Full Text] [Related]
6. Alterations in serum and brain trace element levels after antidepressant treatment: part I. Zinc.
Nowak G; Schlegel-Zawadzka M
Biol Trace Elem Res; 1999 Jan; 67(1):85-92. PubMed ID: 10065601
[TBL] [Abstract][Full Text] [Related]
7. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.
Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR
J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
Biała G
Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
[TBL] [Abstract][Full Text] [Related]
9. [Postsynaptic attack of tricyclic antidepressive agents in the circulatory system].
Bobkiewicz T; Chodera A; Szpunar K; Drutel B
Acta Biol Med Ger; 1975; 34?710():1675-9. PubMed ID: 1233850
[TBL] [Abstract][Full Text] [Related]
10. Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?
Lahmame A; del Arco C; Pazos A; Yritia M; Armario A
Eur J Pharmacol; 1997 Oct; 337(2-3):115-23. PubMed ID: 9430405
[TBL] [Abstract][Full Text] [Related]
11. Novel neurological and immunological targets for salicylate-based phytopharmaceuticals and for the anti-depressant imipramine.
Ulrich-Merzenich G; Kelber O; Koptina A; Freischmidt A; Heilmann J; Müller J; Zeitler H; Seidel MF; Ludwig M; Heinrich EU; Winterhoff H
Phytomedicine; 2012 Jul; 19(10):930-9. PubMed ID: 22743246
[TBL] [Abstract][Full Text] [Related]
12. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A
Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
[TBL] [Abstract][Full Text] [Related]
13. The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression.
Sánchez C; Papp M
Behav Pharmacol; 2000 Apr; 11(2):117-24. PubMed ID: 10877116
[TBL] [Abstract][Full Text] [Related]
14. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
Klimek V; Zak-Knapik J; Mackowiak M
J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the acute effects of a tricyclic and a MAOI antidepressant on septal driving of hippocampal rhythmical slow activity.
Zhu XO; McNaughton N
Psychopharmacology (Berl); 1994 Mar; 114(2):337-44. PubMed ID: 7838927
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.
Stemmelin J; Cohen C; Terranova JP; Lopez-Grancha M; Pichat P; Bergis O; Decobert M; Santucci V; Françon D; Alonso R; Stahl SM; Keane P; Avenet P; Scatton B; le Fur G; Griebel G
Neuropsychopharmacology; 2008 Feb; 33(3):574-87. PubMed ID: 17460614
[TBL] [Abstract][Full Text] [Related]
17. Effect of antidepressant drugs on 6-OHDA-treated mice in the FST.
Chenu F; Dailly E; Bourin M
Eur Neuropsychopharmacol; 2007 Feb; 17(3):187-93. PubMed ID: 16757155
[TBL] [Abstract][Full Text] [Related]
18. [Update Opipramol].
Gahr M; Hiemke C; Connemann BJ
Fortschr Neurol Psychiatr; 2017 Mar; 85(3):139-145. PubMed ID: 28320023
[TBL] [Abstract][Full Text] [Related]
19. [Action of various tricyclic antidepressive agents on the estrous cycle of the female rat].
Lanza M; Chichmanian RM; Goude F
C R Seances Soc Biol Fil; 1970; 164(6):1300-3. PubMed ID: 4252365
[No Abstract] [Full Text] [Related]
20. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.
Müller WE; Rolli M; Schäfer C; Hafner U
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():102-7. PubMed ID: 9342769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
